Anti-Infectives Archives

Gilead COVID drug takes top spot for U.S. hospital spending – report

Anti-Infectives, Antivirals, Blockbusters, Coronavirus Disease (COVID-19) Pandemic, Costs, COVID-19 Therapeutic, Gilead, Hospitals, Humira, Pricing, Remdesivir, Therapeutics, United States, Wall Street Estimates

Gilead Sciences Inc.’s COVID-19 drug remdesivir during 2021 overtook AbbVie Inc.’s 20-year-old arthritis drug Humira as the medicine that U.S. hospitals spent the most on, according to Vizient Inc., a purchasing group used by about half the nation’s hospitals.

Pfizer Acquires Amplyx

Acquisitions, Anti-Infectives, Antimicrobials, Business, Candida auris, Clinical Data, Fungal Infections, Pfizer, Series C

Pfizer is expanding the company’s presence in infectious diseases with the acquisition of San Diego-based Amplyx Pharmaceuticals and the lead antifungal compound Fosmanogepix (APX001).

Pfizer to Organize for Future Growth

Anti-Infectives, Biosimilars, Business, Consumer Healthcare, Hospital Products, Immunology, Inflammation, Internal Medicine, Oncology, Rare Diseases, Reorganization, Sterile Injectable Medicines, Vaccines

Pfizer Inc. announced that the company will organize into three businesses: Innovative Medicines, Established Medicines, and Consumer Healthcare.